Related Experiment Video

Updated: Jul 5, 2026

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

[Concepts for clinical testing of biological agents exemplified for vaccines]

Cedrik M Britten1

  • 1Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. c.m.britten@lumc.nl

Onkologie
|June 14, 2008
PubMed

Insights

Clinical trial development standards need updating for biologics, distinct from cytotoxic drugs. Adapting these standards ensures promising antitumor therapies, like therapeutic vaccines, reach patients without compromising safety.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Context:

  • Classical cytotoxic drug development paradigms do not adequately address the unique characteristics of biologics.
  • Current clinical trial standards, based on cytotoxic agents, may hinder the development of novel biologic therapies.
  • Biologics, including therapeutic tumor vaccines, possess distinct properties requiring tailored clinical evaluation.

Purpose:

  • To highlight the inadequacy of current clinical oncology drug development frameworks for biologics.
  • To advocate for the reconsideration and modification of clinical development standards for biologics.
  • To propose an agent-specific adjustment of clinical development paradigms to improve success rates for novel biologics.

Summary:

  • Biologics differ significantly from cytotoxic drugs, necessitating revised clinical development approaches.
  • Existing oncology drug development models fail to account for crucial aspects of biologic agents.
  • Modifying clinical trial standards to meet the specific needs of biologics can enhance their successful progression through development.

Impact:

  • Successful adaptation of clinical development paradigms will increase the number of biologics reaching patients.
  • Revised standards will ensure promising antitumor biologics, such as therapeutic vaccines, achieve clinical significance.
  • Maintaining high safety and quality standards is paramount during the adaptation of biologic development frameworks.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...